Ongoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors
Patrick Schöffski(Rega Institute for Medical Research), D. Garfield(University of Colorado Cancer Center), Aleck Hercbergs(Cleveland Clinic), Pascal Wolter(Rega Institute for Medical Research)
Cited by 1Open Access
Abstract
Ongoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors
Related Papers
No related papers found
Powered by citation graph analysis